Rhumatologie

ARE THERE FACTORS INFLUENCING THE CLINICAL VS ULTRASOUND AGREEMENT IN RHEUMATOID ARTHRITIS? 

EULAR 2012

M. Le Boedec , S. Jousse-Joulin , J.-F. Ferlet , T. Marhadour , G. Chales , L. Grange , C. Hacquard-bouder , D. Loeuille , J. Sellam , J.-D. Albert , J. Bentin , I. Chary-Valckenaere , M.-A. d’Agostino , F. Etchepare , P. Gaudin , C. Hudry , M. Dougados , A. Saraux

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL
Rhumatologie

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL

Treat to target in axial spondyloarthritis: From its concept to its implementation
Rhumatologie

Treat to target in axial spondyloarthritis: From its concept to its implementation